Philippe Mougin

Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million.

Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million.

Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million.

Part of Phinex SAS, Cenexi - Laboratoires Thissen SA is a development and subcontracting Belgian company specializing in sterile and organic products. Founded in 2012, the company is based in Braine l'Alleud, Belgium. Cenexi partners with pharmaceutical laboratories and biotechs to develop and manufacture innovative drugs. The company's expert entity, Cenexi Services, provides formulation, analytical and galleic developments, industrial transfer, and regulatory support. The company pursues a dynamic recruitment policy, hiring around 125 positions in France and 50 in Belgium every year.

Part of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Phixen SAS is an investment holding French company. The company is based in Fontenay-sous-Bois, France. Founded in 2015. Phixen was acquired by Gland Pharma International Pte Ltd (Singapore) on April 27, 2023 for $124.77 million.